CDH1 and breast cancer: In addition, we determined a molecular mechanism by which DNMT3B7 promotes tumor progression in breast cancer cells through hypermethylation and loss of CDH1/E-cadherin expression, altered β-catenin localization, and subsequent changes in cell adhesion, proliferation, and growth in soft agar (Fig. 5).